nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP2D6—Hydroxyurea—head and neck cancer	0.399	0.567	CbGbCtD
Ciclesonide—CYP2D6—Vinblastine—head and neck cancer	0.141	0.201	CbGbCtD
Ciclesonide—CYP3A4—Vinblastine—head and neck cancer	0.0897	0.128	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—head and neck cancer	0.074	0.105	CbGbCtD
Ciclesonide—Nasal discomfort—Fluorouracil—head and neck cancer	0.0137	0.0721	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.012	0.122	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00798	0.0808	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.0059	0.0597	CbGpPWpGaD
Ciclesonide—Ulcer—Hydroxyurea—head and neck cancer	0.00573	0.0303	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00568	0.0575	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—CEBPA—head and neck cancer	0.00567	0.0574	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—XRCC1—head and neck cancer	0.00462	0.0468	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00455	0.046	CbGpPWpGaD
Ciclesonide—Oral candidiasis—Docetaxel—head and neck cancer	0.00443	0.0234	CcSEcCtD
Ciclesonide—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00417	0.022	CcSEcCtD
Ciclesonide—Laryngeal pain—Docetaxel—head and neck cancer	0.00413	0.0218	CcSEcCtD
Ciclesonide—Ulcer—Fluorouracil—head and neck cancer	0.00413	0.0218	CcSEcCtD
Ciclesonide—Face oedema—Hydroxyurea—head and neck cancer	0.0038	0.0201	CcSEcCtD
Ciclesonide—Rhinorrhoea—Docetaxel—head and neck cancer	0.00348	0.0184	CcSEcCtD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00339	0.0343	CbGpPWpGaD
Ciclesonide—Swelling—Fluorouracil—head and neck cancer	0.00321	0.017	CcSEcCtD
Ciclesonide—Chest discomfort—Docetaxel—head and neck cancer	0.00318	0.0168	CcSEcCtD
Ciclesonide—Oropharyngeal pain—Docetaxel—head and neck cancer	0.0031	0.0164	CcSEcCtD
Ciclesonide—Weight increased—Hydroxyurea—head and neck cancer	0.0031	0.0163	CcSEcCtD
Ciclesonide—Infestation—Hydroxyurea—head and neck cancer	0.00303	0.016	CcSEcCtD
Ciclesonide—Infestation NOS—Hydroxyurea—head and neck cancer	0.00303	0.016	CcSEcCtD
Ciclesonide—CES1—larynx—head and neck cancer	0.00302	0.358	CbGeAlD
Ciclesonide—Haemoglobin—Vinblastine—head and neck cancer	0.003	0.0158	CcSEcCtD
Ciclesonide—Haemorrhage—Vinblastine—head and neck cancer	0.00299	0.0158	CcSEcCtD
Ciclesonide—Pharyngitis—Vinblastine—head and neck cancer	0.00296	0.0156	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—RARB—head and neck cancer	0.00296	0.03	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00292	0.0296	CbGpPWpGaD
Ciclesonide—Haemoglobin—Hydroxyurea—head and neck cancer	0.00274	0.0145	CcSEcCtD
Ciclesonide—Haemorrhage—Hydroxyurea—head and neck cancer	0.00272	0.0144	CcSEcCtD
Ciclesonide—Candida infection—Docetaxel—head and neck cancer	0.00269	0.0142	CcSEcCtD
Ciclesonide—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00253	0.0134	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—TYMS—head and neck cancer	0.00241	0.0244	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—TGFA—head and neck cancer	0.00235	0.0238	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00234	0.0237	CbGpPWpGaD
Ciclesonide—Swelling—Docetaxel—head and neck cancer	0.00232	0.0122	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00228	0.012	CcSEcCtD
Ciclesonide—Hypertension—Vinblastine—head and neck cancer	0.00224	0.0118	CcSEcCtD
Ciclesonide—Pneumonia—Fluorouracil—head and neck cancer	0.0022	0.0116	CcSEcCtD
Ciclesonide—Infestation NOS—Fluorouracil—head and neck cancer	0.00218	0.0115	CcSEcCtD
Ciclesonide—Infestation—Fluorouracil—head and neck cancer	0.00218	0.0115	CcSEcCtD
Ciclesonide—Urinary tract infection—Fluorouracil—head and neck cancer	0.00212	0.0112	CcSEcCtD
Ciclesonide—Conjunctivitis—Fluorouracil—head and neck cancer	0.00212	0.0112	CcSEcCtD
Ciclesonide—Epistaxis—Fluorouracil—head and neck cancer	0.00206	0.0109	CcSEcCtD
Ciclesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00205	0.0207	CbGpPWpGaD
Ciclesonide—Sinusitis—Fluorouracil—head and neck cancer	0.00205	0.0108	CcSEcCtD
Ciclesonide—Pain in extremity—Docetaxel—head and neck cancer	0.00204	0.0108	CcSEcCtD
Ciclesonide—Haemoglobin—Fluorouracil—head and neck cancer	0.00197	0.0104	CcSEcCtD
Ciclesonide—Rhinitis—Fluorouracil—head and neck cancer	0.00197	0.0104	CcSEcCtD
Ciclesonide—Haemorrhage—Fluorouracil—head and neck cancer	0.00196	0.0103	CcSEcCtD
Ciclesonide—Pharyngitis—Fluorouracil—head and neck cancer	0.00195	0.0103	CcSEcCtD
Ciclesonide—Infection—Hydroxyurea—head and neck cancer	0.00192	0.0101	CcSEcCtD
Ciclesonide—Nasopharyngitis—Docetaxel—head and neck cancer	0.00183	0.00966	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.0018	0.00952	CcSEcCtD
Ciclesonide—Bronchospasm—Docetaxel—head and neck cancer	0.00174	0.00918	CcSEcCtD
Ciclesonide—Dyspnoea—Hydroxyurea—head and neck cancer	0.00172	0.00911	CcSEcCtD
Ciclesonide—Dyspepsia—Hydroxyurea—head and neck cancer	0.0017	0.00899	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00167	0.00882	CcSEcCtD
Ciclesonide—Fatigue—Hydroxyurea—head and neck cancer	0.00167	0.00881	CcSEcCtD
Ciclesonide—Weight increased—Docetaxel—head and neck cancer	0.00161	0.00849	CcSEcCtD
Ciclesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00159	0.0161	CbGpPWpGaD
Ciclesonide—Pneumonia—Docetaxel—head and neck cancer	0.00159	0.00837	CcSEcCtD
Ciclesonide—Infestation NOS—Docetaxel—head and neck cancer	0.00158	0.00832	CcSEcCtD
Ciclesonide—Infestation—Docetaxel—head and neck cancer	0.00158	0.00832	CcSEcCtD
Ciclesonide—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00153	0.0155	CbGpPWpGaD
Ciclesonide—Conjunctivitis—Docetaxel—head and neck cancer	0.00153	0.00809	CcSEcCtD
Ciclesonide—Asthenia—Vinblastine—head and neck cancer	0.00152	0.00804	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—head and neck cancer	0.00151	0.0153	CbGpPWpGaD
Ciclesonide—Epistaxis—Docetaxel—head and neck cancer	0.00149	0.00785	CcSEcCtD
Ciclesonide—Chest pain—Fluorouracil—head and neck cancer	0.00145	0.00767	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—CEBPA—head and neck cancer	0.00142	0.0144	CbGpPWpGaD
Ciclesonide—Haemoglobin—Docetaxel—head and neck cancer	0.00142	0.00751	CcSEcCtD
Ciclesonide—Rhinitis—Docetaxel—head and neck cancer	0.00142	0.00749	CcSEcCtD
Ciclesonide—Haemorrhage—Docetaxel—head and neck cancer	0.00141	0.00747	CcSEcCtD
Ciclesonide—Pharyngitis—Docetaxel—head and neck cancer	0.0014	0.00741	CcSEcCtD
Ciclesonide—Dizziness—Vinblastine—head and neck cancer	0.0014	0.00741	CcSEcCtD
Ciclesonide—Asthenia—Hydroxyurea—head and neck cancer	0.00139	0.00733	CcSEcCtD
Ciclesonide—Infection—Fluorouracil—head and neck cancer	0.00138	0.0073	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—GSTM1—head and neck cancer	0.00137	0.0138	CbGpPWpGaD
Ciclesonide—Headache—Vinblastine—head and neck cancer	0.00133	0.00702	CcSEcCtD
Ciclesonide—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.00128	0.013	CbGpPWpGaD
Ciclesonide—Dizziness—Hydroxyurea—head and neck cancer	0.00128	0.00675	CcSEcCtD
Ciclesonide—Immune system disorder—Docetaxel—head and neck cancer	0.00128	0.00675	CcSEcCtD
Ciclesonide—Mediastinal disorder—Docetaxel—head and neck cancer	0.00127	0.00673	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00127	0.0067	CcSEcCtD
Ciclesonide—Nausea—Vinblastine—head and neck cancer	0.00126	0.00665	CcSEcCtD
Ciclesonide—Dyspnoea—Fluorouracil—head and neck cancer	0.00124	0.00656	CcSEcCtD
Ciclesonide—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00123	0.0125	CbGpPWpGaD
Ciclesonide—Dyspepsia—Fluorouracil—head and neck cancer	0.00123	0.00647	CcSEcCtD
Ciclesonide—Rash—Hydroxyurea—head and neck cancer	0.00122	0.00644	CcSEcCtD
Ciclesonide—Dermatitis—Hydroxyurea—head and neck cancer	0.00122	0.00643	CcSEcCtD
Ciclesonide—Headache—Hydroxyurea—head and neck cancer	0.00121	0.0064	CcSEcCtD
Ciclesonide—Dysgeusia—Docetaxel—head and neck cancer	0.00121	0.00637	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0012	0.00635	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—head and neck cancer	0.00119	0.00629	CcSEcCtD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—head and neck cancer	0.00117	0.0118	CbGpPWpGaD
Ciclesonide—Nausea—Hydroxyurea—head and neck cancer	0.00115	0.00607	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.00114	0.0115	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.00111	0.0113	CbGpPWpGaD
Ciclesonide—Urticaria—Fluorouracil—head and neck cancer	0.00111	0.00584	CcSEcCtD
Ciclesonide—Palpitations—Docetaxel—head and neck cancer	0.00109	0.00575	CcSEcCtD
Ciclesonide—Cough—Docetaxel—head and neck cancer	0.00107	0.00567	CcSEcCtD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00107	0.0109	CbGpPWpGaD
Ciclesonide—Hypertension—Docetaxel—head and neck cancer	0.00106	0.00561	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—head and neck cancer	0.00105	0.00554	CcSEcCtD
Ciclesonide—Arthralgia—Docetaxel—head and neck cancer	0.00105	0.00554	CcSEcCtD
Ciclesonide—Dry mouth—Docetaxel—head and neck cancer	0.00103	0.00541	CcSEcCtD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.001	0.0102	CbGpPWpGaD
Ciclesonide—Infection—Docetaxel—head and neck cancer	0.000999	0.00527	CcSEcCtD
Ciclesonide—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000963	0.00975	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000953	0.00965	CbGpPWpGaD
Ciclesonide—Dizziness—Fluorouracil—head and neck cancer	0.000921	0.00486	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000916	0.00484	CcSEcCtD
Ciclesonide—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000913	0.00924	CbGpPWpGaD
Ciclesonide—Dyspnoea—Docetaxel—head and neck cancer	0.000896	0.00473	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—head and neck cancer	0.000885	0.00467	CcSEcCtD
Ciclesonide—Rash—Fluorouracil—head and neck cancer	0.000878	0.00464	CcSEcCtD
Ciclesonide—Dermatitis—Fluorouracil—head and neck cancer	0.000877	0.00463	CcSEcCtD
Ciclesonide—Headache—Fluorouracil—head and neck cancer	0.000872	0.00461	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000868	0.00458	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—head and neck cancer	0.000867	0.00458	CcSEcCtD
Ciclesonide—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000839	0.00849	CbGpPWpGaD
Ciclesonide—Nausea—Fluorouracil—head and neck cancer	0.000827	0.00437	CcSEcCtD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000807	0.00817	CbGpPWpGaD
Ciclesonide—CES1—neck—head and neck cancer	0.0008	0.095	CbGeAlD
Ciclesonide—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.000763	0.00772	CbGpPWpGaD
Ciclesonide—Asthenia—Docetaxel—head and neck cancer	0.000721	0.00381	CcSEcCtD
Ciclesonide—Dizziness—Docetaxel—head and neck cancer	0.000665	0.00351	CcSEcCtD
Ciclesonide—Rash—Docetaxel—head and neck cancer	0.000634	0.00335	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—head and neck cancer	0.000633	0.00334	CcSEcCtD
Ciclesonide—Headache—Docetaxel—head and neck cancer	0.00063	0.00332	CcSEcCtD
Ciclesonide—Nausea—Docetaxel—head and neck cancer	0.000597	0.00315	CcSEcCtD
Ciclesonide—CES1—connective tissue—head and neck cancer	0.000573	0.0681	CbGeAlD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000533	0.00539	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000526	0.00532	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000513	0.00519	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.0005	0.00506	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.00049	0.00496	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000483	0.00489	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000482	0.00488	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000452	0.00457	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000432	0.00437	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000431	0.00436	CbGpPWpGaD
Ciclesonide—CES1—lymphoid tissue—head and neck cancer	0.000419	0.0498	CbGeAlD
Ciclesonide—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000404	0.00409	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000403	0.00408	CbGpPWpGaD
Ciclesonide—CES1—thyroid gland—head and neck cancer	0.000381	0.0452	CbGeAlD
Ciclesonide—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000368	0.00372	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000363	0.00368	CbGpPWpGaD
Ciclesonide—NR3C1—neck—head and neck cancer	0.00035	0.0416	CbGeAlD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000348	0.00353	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000346	0.0035	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000344	0.00348	CbGpPWpGaD
Ciclesonide—CES1—head—head and neck cancer	0.000338	0.0401	CbGeAlD
Ciclesonide—SERPINA6—head—head and neck cancer	0.000337	0.0401	CbGeAlD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000329	0.00333	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00032	0.00324	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000316	0.0032	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.00029	0.00294	CbGpPWpGaD
Ciclesonide—NR3C1—parotid gland—head and neck cancer	0.000285	0.0339	CbGeAlD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000282	0.00286	CbGpPWpGaD
Ciclesonide—NR3C1—saliva-secreting gland—head and neck cancer	0.000273	0.0324	CbGeAlD
Ciclesonide—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.000263	0.00266	CbGpPWpGaD
Ciclesonide—NR3C1—connective tissue—head and neck cancer	0.000251	0.0298	CbGeAlD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000247	0.0025	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.000245	0.00248	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000242	0.00245	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000239	0.00242	CbGpPWpGaD
Ciclesonide—NR3C1—epithelium—head and neck cancer	0.000238	0.0283	CbGeAlD
Ciclesonide—CES1—lymph node—head and neck cancer	0.000236	0.0281	CbGeAlD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00023	0.00232	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000229	0.00232	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000226	0.00229	CbGpPWpGaD
Ciclesonide—NR3C1—trachea—head and neck cancer	0.000211	0.025	CbGeAlD
Ciclesonide—CYP2D6—Metabolism—UROD—head and neck cancer	0.000202	0.00204	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RARB—head and neck cancer	0.000195	0.00197	CbGpPWpGaD
Ciclesonide—NR3C1—lymphoid tissue—head and neck cancer	0.000183	0.0218	CbGeAlD
Ciclesonide—NR3C1—Gene Expression—YAP1—head and neck cancer	0.000177	0.00179	CbGpPWpGaD
Ciclesonide—NR3C1—thyroid gland—head and neck cancer	0.000167	0.0198	CbGeAlD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000166	0.00168	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000158	0.0016	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000156	0.00158	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.00015	0.00152	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000148	0.0015	CbGpPWpGaD
Ciclesonide—NR3C1—head—head and neck cancer	0.000148	0.0176	CbGeAlD
Ciclesonide—CYP3A4—Metabolism—UROD—head and neck cancer	0.000132	0.00134	CbGpPWpGaD
Ciclesonide—CYP2D6—head—head and neck cancer	0.00011	0.0131	CbGeAlD
Ciclesonide—NR3C1—lymph node—head and neck cancer	0.000103	0.0123	CbGeAlD
Ciclesonide—CYP2D6—Metabolism—NAT2—head and neck cancer	8.38e-05	0.000848	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH1—head and neck cancer	7.98e-05	0.000808	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DPYD—head and neck cancer	7.35e-05	0.000744	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—YAP1—head and neck cancer	6.97e-05	0.000706	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NAT2—head and neck cancer	5.48e-05	0.000555	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DPYD—head and neck cancer	4.8e-05	0.000486	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—YAP1—head and neck cancer	4.56e-05	0.000461	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK3—head and neck cancer	4.42e-05	0.000447	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TYMS—head and neck cancer	4.19e-05	0.000424	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—head and neck cancer	4.14e-05	0.000419	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPX1—head and neck cancer	3.96e-05	0.000401	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.92e-05	0.000397	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—head and neck cancer	2.98e-05	0.000302	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TYMS—head and neck cancer	2.74e-05	0.000277	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.71e-05	0.000274	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPX1—head and neck cancer	2.59e-05	0.000262	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.57e-05	0.00026	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.33e-05	0.000236	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—head and neck cancer	2.03e-05	0.000206	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.53e-05	0.000154	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.44e-05	0.000145	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—head and neck cancer	1.33e-05	0.000135	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—head and neck cancer	1.17e-05	0.000119	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—head and neck cancer	9.39e-06	9.5e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—head and neck cancer	7.67e-06	7.76e-05	CbGpPWpGaD
